AzTrials
AzTrials

Premature BirthLiMoNidNCT02034617

Evaluation of a Parent-Infant Interaction Model

A study testing LiMoNid in people with Premature Birth, run by Linkoeping University at 1 site in Sweden.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

When becoming a parent of a preterm infant there is an increased risk of stress. There are a number of studies showing that parental stress has a negative impact on their engagement with their child. Read more about this study

Who is it for?
Ages Up to 96 hours
Conditions the study is for
Premature Birth
What is being tested?
LiMoNid
Could I receive a placebo?
No, everyone receives an active treatment
How many people
140 participants
Where
1 siteSweden
Study dates
1 Jan 2014to 31 May 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Up to 96 hours
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Preterm infants born 30-36 weeks gestational age without known major malformations or complications
  • Families living in the county of Ostergotland, Sweden
  • Swedish speaking parents
  • Single or duplex birth

Who cannot join

  • Complications encountered during hospital stay that are known to affect cognition

Trial locations and contacts

1 site in 1 country.

Sweden1 site
  • Linkoping University Hospital

    Linköping, 581 85

Other trials in Sweden

About this study

Official title: Evaluation of a Parent-Infant Interaction Model in the Neonatal Intensive Care

When becoming a parent of a preterm infant there is an increased risk of stress. There are a number of studies showing that parental stress has a negative impact on their engagement with their child. Other studies, on the other hand, show that different intervention programs with the aim to strengthen the relationship can decrease parental stress and hence affect the parent-infant interaction in a positive way. Structured intervention programs for preterm infants have also been successful in improving the infants' cognitive functions.

The investigators have developed a program with the aim to strengthen the parent-infant interaction for late preterm infants. The observational program is called LiMoNid. Our hypothesis is that LiMoNid will strengthen the parents' own parental abilities and give them a deeper understanding of their child. They will hopefully develop more skills on how to communicate with their child; to see, interpret, understand and approach the child, which can lead to an improved parent-child interaction. Parental stress may also be reduced by increased understanding and control. Regarding the child itself, we hypothesize that the psychological development will be affected depending on the communication with the caregiver and depending on the support it has received in expressing its feelings and needs. The emotional regulation should be strengthened by such an intervention.

The aim is to study if LiMoNid can have an impact on cognition, stress, parent-child interaction.

Read the detailed description

The Design is a randomised controlled study in two groups; intervention group versus standard care. Parents who meet the inclusion criteria are given oral and written information about the study aim and procedure and are asked for participation. If the parents consent they will be randomised to one of two groups. Follow-ups will be conducted at 1 month, 4 months, 10-12 months corrected age and when the child is 4 years.

Conditions
Premature Birth
Being tested
LiMoNid
Keywords
Cognition, Family nursing, Infant, premature, Object attachment, Stress, physiological, Stress, psychological
Medical subject headings
Premature Birth, Stress, Psychological

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • LiMoNidBehavioural

    One LiMoNid observation will be performed on day 1-3 post birth, one in time of discharge, and one in the home when the infant has reached 40 weeks (+/- 2 week). All observations are performed in presence of and in collaboration with the parents with the outspoken aim to guide the parents to learn how to read and respond to their infant' signals

Study groups in NCT02034617
Study groupRoleWhat they receive
Standard careNo interventionThe family receive standard care when enrolled in the Neonatal intensive care unit
ObservationExperimentalThe family receive standard care when enrolled in the Neonatal intensive care unit and are also included in an observational program called LiMoNid.
Receives: Behavioral: LiMoNid

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Cognitive abilities

    Bayley Scales of Infant Development

    Measured: 11 months

Secondary outcomes (1)
  1. Stress reactivity

    Salivary cortisol reactivity in relation to bath

    Measured: 1 month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Jan 2014 (estimated)
  2. Study start1 Jan 2014
  3. Primary completion31 Aug 2021
  4. Study completion31 May 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
140 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02034617
Sponsor's protocol ID
LinkoepingU
Acronym
LiMoNid
Status last verified
Jun 2024
First submitted
19 Dec 2013
Last updated
11 Jun 2024
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Publications

  • Helmer CS, Thornberg UB, Abrahamsson T, Morelius E. Mothers' experiences of a new early collaborative intervention, the EACI, in the neonatal period: A qualitative study. J Clin Nurs. 2023 Jun;32(11-12):2892-2902. doi: 10.1111/jocn.16412. Epub 2022 Jun 14.

    PubMed 35702001
  • Helmer CS, Thornberg UB, Morelius E. An Early Collaborative Intervention Focusing on Parent-Infant Interaction in the Neonatal Period. A Descriptive Study of the Developmental Framework. Int J Environ Res Public Health. 2021 Jun 21;18(12):6656. doi: 10.3390/ijerph18126656.

    PubMed 34205660
  • Helmer CS, Thornberg UB, Abrahamsson T, Morelius E. Impacts of the Early Collaborative Intervention on mother-preterm infant interaction at one month of age: Secondary analysis of a randomized controlled trial. Int J Nurs Stud Adv. 2026 Feb 9;10:100507. doi: 10.1016/j.ijnsa.2026.100507. eCollection 2026 Jun.

    PubMed 41782918
  • Birberg Thornberg U, Koch FS, Helmer CS, Tell J, Nyberg E, Abrahamsson T, Morelius E. Moderate-To-Late Preterm Infants Benefit From the Early Collaborative Intervention: Primary Outcomes of an RCT. Acta Paediatr. 2025 Nov;114(11):2838-2846. doi: 10.1111/apa.70173. Epub 2025 Jun 13.

    PubMed 40511708

Questions about this trial

What is this clinical trial studying?

A study testing LiMoNid in people with Premature Birth, run by Linkoeping University at 1 site in Sweden.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 11 Jun 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Cognitive abilities (time frame: 11 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02034617, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Jun 2024.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in